These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 6342354

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Economic Evaluation of the Combined Use of Warfarin and Low-dose Aspirin Versus Warfarin Alone in Mechanical Valve Prostheses.
    El-Hamamsy MH, Elsisi GH, Eldessouki R, Elmazar MM, Taha AS, Awad BF, Elmansy H.
    Appl Health Econ Health Policy; 2016 Aug; 14(4):431-440. PubMed ID: 27028445
    [Abstract] [Full Text] [Related]

  • 24. [Dipyridamole and warfarin in patients with artificial heart valve prosthesis: double-blind tests].
    Ciavarella N, Antoncecchi S, D'Elia N.
    Cardiologia; 1985 Apr; 30(4):301-7. PubMed ID: 3914360
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Comparing warfarin with aspirin after biological aortic valve replacement: a prospective study.
    Gherli T, Colli A, Fragnito C, Nicolini F, Borrello B, Saccani S, D'Amico R, Beghi C.
    Circulation; 2004 Aug 03; 110(5):496-500. PubMed ID: 15289387
    [Abstract] [Full Text] [Related]

  • 27. Anticoagulation therapy with combined low dose aspirin and warfarin following mechanical heart valve replacement.
    Dong MF, Ma ZS, Ma SJ, Chai SD, Tang PZ, Yao DK, Wang LX.
    Thromb Res; 2011 Nov 03; 128(5):e91-4. PubMed ID: 21813162
    [Abstract] [Full Text] [Related]

  • 28. The long-term risk of warfarin sodium therapy and the incidence of thromboembolism in children after prosthetic cardiac valve replacement.
    Stewart S, Cianciotta D, Alexson C, Manning J.
    J Thorac Cardiovasc Surg; 1987 Apr 03; 93(4):551-4. PubMed ID: 3561002
    [Abstract] [Full Text] [Related]

  • 29. Oral anticoagulant treatment with and without aspirin.
    Altman R, Rouvier J, Gurfinkel E.
    Thromb Haemost; 1995 Jul 03; 74(1):506-10. PubMed ID: 8578514
    [Abstract] [Full Text] [Related]

  • 30. Reduced anticoagulation after mechanical aortic valve replacement: interim results from the prospective randomized on-X valve anticoagulation clinical trial randomized Food and Drug Administration investigational device exemption trial.
    Puskas J, Gerdisch M, Nichols D, Quinn R, Anderson C, Rhenman B, Fermin L, McGrath M, Kong B, Hughes C, Sethi G, Wait M, Martin T, Graeve A, PROACT Investigators.
    J Thorac Cardiovasc Surg; 2014 Apr 03; 147(4):1202-1210; discussion 1210-1. PubMed ID: 24512654
    [Abstract] [Full Text] [Related]

  • 31. Prevalence of Guideline-Discordant Aspirin Use and Associated Adverse Events in Patients on Warfarin for Mechanical Valve Replacement.
    Haymart B, Kong X, Ali M, Schaefer JK, Froehlich JB, Ryan N, Stallings B, Barnes GD, Kaatz S.
    Am J Med; 2024 May 03; 137(5):449-453. PubMed ID: 38280559
    [Abstract] [Full Text] [Related]

  • 32. Low-intensity oral anticoagulation plus low-dose aspirin versus high-intensity oral anticoagulation alone: a randomized trial in patients with mechanical prosthetic heart valves.
    Meschengieser SS, Fondevila CG, Frontroth J, Santarelli MT, Lazzari MA.
    J Thorac Cardiovasc Surg; 1997 May 03; 113(5):910-6. PubMed ID: 9159625
    [Abstract] [Full Text] [Related]

  • 33. Thrombotic and bleeding complications of prosthetic heart valves.
    Edmunds LH.
    Ann Thorac Surg; 1987 Oct 03; 44(4):430-45. PubMed ID: 3310938
    [Abstract] [Full Text] [Related]

  • 34. Comparison of anticoagulation regimens after Carpentier-Edwards aortic or mitral valve replacement.
    Blair KL, Hatton AC, White WD, Smith LR, Lowe JE, Wolfe WG, Young WG, Oldham HN, Douglas JM, Glower DD.
    Circulation; 1994 Nov 03; 90(5 Pt 2):II214-9. PubMed ID: 7955256
    [Abstract] [Full Text] [Related]

  • 35. Proceedings: Arterial thromboembolism and prosthetic heart valves. Effects of acetylsalicylic acid.
    Dale J, Myhre E, Storstein O, Stormorken H.
    Thromb Diath Haemorrh; 1975 Nov 15; 34(2):587-8. PubMed ID: 1105879
    [No Abstract] [Full Text] [Related]

  • 36. The prevention of prosthetic valve thromboembolism. Uses and limitations of anti-platelet drugs.
    Shattil SJ, Brass LF.
    Int J Cardiol; 1983 Apr 15; 3(1):87-91. PubMed ID: 6852996
    [No Abstract] [Full Text] [Related]

  • 37. Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm?
    ElBardissi AW, DiBardino DJ, Chen FY, Yamashita MH, Cohn LH.
    J Thorac Cardiovasc Surg; 2010 May 15; 139(5):1137-45. PubMed ID: 20303508
    [Abstract] [Full Text] [Related]

  • 38. Effects of combination therapy with low-dose aspirin and warfarin on platelet functions after heart valve replacement.
    Kobune K, Inoue M, Morikawa M, Tsuboi M, Takanami Y, Iwane Y, Kudo T.
    Res Commun Chem Pathol Pharmacol; 1991 Nov 15; 74(2):153-65. PubMed ID: 1811279
    [Abstract] [Full Text] [Related]

  • 39. Cerebral microembolization after bioprosthetic aortic valve replacement: comparison of warfarin plus aspirin versus aspirin only.
    Al-Atassi T, Lam K, Forgie M, Boodhwani M, Rubens F, Hendry P, Masters R, Goldstein W, Bedard P, Mesana T, Ruel M.
    Circulation; 2012 Sep 11; 126(11 Suppl 1):S239-44. PubMed ID: 22965989
    [Abstract] [Full Text] [Related]

  • 40. Valvular Heart Disease in Adults: Management of Prosthetic Heart Valves.
    Trujillo JF, Hollenberg SM.
    FP Essent; 2017 Jun 11; 457():23-29. PubMed ID: 28671806
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.